Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T14:12:28.124Z Has data issue: false hasContentIssue false
  • English
  • Français

Low cholesterol and violent death: The evidence, the gaps, the theory and the practical implications

Published online by Cambridge University Press:  13 June 2014

Ronán M Conroy
Ronán M Conroy*
Affiliation:
Department of Epidemiology and Preventive Medicine, Royal College of Surgeons in Ireland, Mercer Building, Dublin 2, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

AccidentsCholesterolDepressionHostilitySerotoninSuicide
Type
Editorial
Information
Irish Journal of Psychological Medicine , Volume 10 , Issue 2 , June 1993 , pp. 67 - 70
Copyright
Copyright © Cambridge University Press 1993

References

1.Muldoon, M, Manchuch, S, Mathews, K. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309–14.CrossRefGoogle ScholarPubMed
2.Lipid Clinics Research Program. The lipid research clinics coronary prevention trial results. JAMA 1984; 251: 351–74.CrossRefGoogle Scholar
3.Virkkunen, M. The lipid research clinics coronary prevention trial results [letter]. JAMA 1985; 253: 635–6.CrossRefGoogle ScholarPubMed
4.Pekkanen, J, Nissinen, A, Punsar, S, Karvonen, M. Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. Arch Intern Med 1989; 149: 1589–91.CrossRefGoogle ScholarPubMed
5.Asberg, M, Traskman, L, Thoren, P. 5-HIAA in cerebrospinal fluid: a biochemical suicide predictor. Arch Gen Psychiatry 1976; 33: 93–7.CrossRefGoogle ScholarPubMed
6. Anon. Serotonin, suicidal behaviour and impulsivity. Lancet 1987; 2: 949–50.Google Scholar
7.Lindberg, G, Rästam, L, Gullberg, B, Eklund, G. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 1992; 305: 277–9.CrossRefGoogle ScholarPubMed
8.Kromhout, D, Katan, M, Menotti, A, Keyes, A, Blomberg, B. Serum cholesterol and long-term death rates from suicide, accidents or violence [letter]. Lancet 1992; 340: 317.CrossRefGoogle ScholarPubMed
9.Jacobs, D, Blackburn, H, Higgins, M, et al.Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046–60.CrossRefGoogle ScholarPubMed
10.Schuit, A, Dekker, J, Schouten, E, Kok, F. Low serum cholesterol and death due to accidents, violence, or suicide. Lancet 1993; 341: 827.CrossRefGoogle ScholarPubMed
11.Marmot, M, Davey Smith, G, Stansfeld, S, et al.Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337: 1387–93.CrossRefGoogle ScholarPubMed
12.Lewis, B, Katan, M, Merkx, I, et al.Towards an improved lipid-lowering diet: aditive effects of changes in nutrient intake. Lancet. 1981; ii: 1310–3.CrossRefGoogle Scholar
13.Conroy, R. Serum triglycerides and aggression in the general population, [letter]. Lancet 1993; 341: 176.CrossRefGoogle Scholar
14.Strandbert, T, Valvanne, J, Tilvis, R. Low serum lipids and depression. Lancet 1993; 341: 433–4.CrossRefGoogle Scholar
15.Preston Mason, R, Herbette, L, Silverman, D. Can altering serum cholesterol affect neurologic function? J Mol Cell Cardiol 1991; 23: 1339–42.CrossRefGoogle Scholar
16.Engelberg, H. Low serum cholesterol and suicide. Lancet 1992; 339: 727–9.CrossRefGoogle ScholarPubMed
17.Guicheney, P, Devynck, MA, Cloix, JF, Pernollet, MG, Grichois, ML, Meyer, P. Platelet 5-HT content and uptake in essential hypertension: rôle of endogenous dititalis-like factors and plasma cholesterol. J Hypertens 1988; 6: 115–26.CrossRefGoogle ScholarPubMed
18.Spoont, M. Modulatory rôle of serotonin in neural informaito processing: implications for human psychopathology. Psych Bull 1992; 112: 330–50.CrossRefGoogle ScholarPubMed
19.Morgan, R, Palinkas, L, Barrett-Connor, E, Wingard, D. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341: 75–9.CrossRefGoogle ScholarPubMed
20.Palinkas, L, Barrett-Connor, E, Morgan, R, Wingard, D. Serum lipids and depression. Lancet 1993; 341: 563.CrossRefGoogle ScholarPubMed
21.Davey Smith, G, Shipley, M. Serum lipids and depression Lancet 1993; 341: 434.Google Scholar
22.DeAlberto, M, Duicimitière, P, Mailard, P, Alperovitch, A. Serum lipids and depression Lancet 1993; 341: 435.Google Scholar
23.Duits, N, Bos, FM. Depressive symptoms and cholesterol-lowering drugs [letter]. Lancet 1993; 341: 114.CrossRefGoogle ScholarPubMed
24.Report from the Committee of Principal Investigators. A cooperative trial in the primary prevention of ischaemic heart disease using Clofibrate. Br Heart J 1978; 40: 1069–118.CrossRefGoogle Scholar
25.Report from the Committee of Principal Investigators. WHP cooperative trial on primary prevention of ischaemic heart diesease with Clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 1984; ii: 600–04.Google Scholar
26.Weidner, G, Connor, S, Hollis, J, Connor, W. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med 1992; 117: 820–3.CrossRefGoogle ScholarPubMed
27.Davey Smith, G, Shipley, MJ, Marmot, MG, Rose, G. Plasma cholesterol concentration and mortality. JAMA 1992; 267: 70–6.CrossRefGoogle Scholar
28.Lipid Clinics Research Program. The Lipid Clinics Primary Prevention Trial results: I Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351–74.CrossRefGoogle Scholar
29.Holme, I. Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis. Br Heart J 1993; 69: S42–S47.CrossRefGoogle ScholarPubMed
30.Davey Smith, G, Song, F, Sheldon, T. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306: 1357–73.Google Scholar